| Literature DB >> 35573883 |
Fanrong Sun1,2, Ligai Bai1,2,3, Mingxue Li1,2, Changqing Yu1,2, Haiyan Liu1,2,3, Xiaoqiang Qiao1,2,3, Hongyuan Yan1,2,3.
Abstract
In this study, a functionalized covalent-organic framework (COF) was first synthesized using porphyrin as the fabrication unit and showed an edge-curled, petal-like and well-ordered structure. The synthesized COF was then introduced to prepare porous organic polymer monolithic materials (POPMs). Two composite POPM/COF monolithic materials with rod shapes, referred to as sorbent A and sorbent B, were prepared in stainless steel tubes using different monomers. Sorbents A and B exhibited relatively uniform porous structures and enhanced specific surface areas of 153.14 m2/g and 80.01 m2/g, respectively. The prepared composite monoliths were used as in-tube solid-phase extraction (SPE) sorbents combined with HPLC for the on-line extraction and quantitative analytical systems. Indole alkaloids (from Catharanthus roseus G. Don and Uncaria rhynchophylla (Miq.) Miq. Ex Havil.) contained in mouse plasma were extracted and quantitatively analyzed using the online system. The two composite multifunctional monoliths showed excellent clean-up ability for complex biological matrices, as well as superior selectivity for target indole alkaloids. Method validation showed that the RSD values of the repeatability (n=6) were ≤ 3.46%, and the accuracy expressed by the spiked recoveries was in the ranges of 99.38%-100.91% and 96.39%-103.50% for vinca alkaloids and Uncaria alkaloids, respectively. Furthermore, sorbents A and B exhibited strong reusability, with RSD values ≤ 5.32%, which were based on the peak area of the corresponding alkaloids with more than 100 injections. These results indicate that the composite POPM/COF rod-shaped monoliths are promising media as SPE sorbents for extracting trace compounds in complex biological samples.Entities:
Keywords: Alkaloids; Biological samples; Covalent organic frameworks; Monolithic material; Solid-phase extraction
Year: 2020 PMID: 35573883 PMCID: PMC9073138 DOI: 10.1016/j.jpha.2020.12.006
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Scheme 1Synthesis route of TpTph-MA-COF.
Representative composition of the pre-polymerization solution and resulting properties of the POPM/COF sorbents.
| Sorbent | Crosslinker (mL) | Porogen (mL) | COF (mg) | Back pressure | Permeability | BET surface area (m2/g) | |||
|---|---|---|---|---|---|---|---|---|---|
| EDMA | TAIC | n-propyl alcohol | Dodecanol | DMF | |||||
| A1 | 0.35 | – | 0.3 | 0.6 | – | 5 | 14 | 2.08 | 151.73 |
| A2 | 0.45 | – | 0.3 | 0.6 | – | 5 | 18 | 1.62 | 153.14 |
| A3 | 0.55 | – | 0.3 | 0.6 | – | 5 | >2 | <1.42 | 157.13 |
| A4 | 0.45 | – | 0.3 | 0.6 | – | 2 | 7 | 4.15 | 141.54 |
| A5 | 0.45 | – | 0.3 | 0.6 | – | 10 | >26 | <1.12 | 173.19 |
| A6 | 0.45 | – | 0.3 | 0.6 | – | 0 | 5 | 5.82 | 76.33 |
| B1 | 0.45 | 0.45 | 0.7 | 1.0 | 0.2 | 5 | 5 | 5.82 | 76.41 |
| B2 | 0.45 | 0.45 | 0.7 | 1.0 | 0.2 | 10 | 6 | 4.85 | 78.32 |
| B3 | 0.45 | 0.45 | 0.7 | 1.0 | 0.2 | 15 | 9 | 3.23 | 80.01 |
| B4 | 0.45 | 0.45 | 0.7 | 1.0 | 0.2 | – | 5 | 5.82 | 33.25 |
Sorbents A were prepared using DAM (0.4 mL) as the monomer, and initiated by BPO/DMA (0.01 g/50 μL); Sorbents B were prepared using THFMA (0.2 mL) as the monomer, and initiated by BPO/DMA (0.01 g/30 μL).
MeOH was used as the mobile phases with a flow rate of 1.0 mL/min.
Permeability was calculated following Darcy's law using MeOH (the viscosity is 0.58 × 10−3 Pa‧s at 25 °C) as the mobile phase.
Fig. 1(A) Petal-like scanning electron microscope image, (B) IR spectra, (C) powder X-ray diffraction pattern, and (D) adsorption-desorption isotherm of TpTph-MA-COF.
Fig. 2SEM images of sorbents A and B. Sorbents A1–A6 are successively marked as A–F, and B1–B4 marked as G–J.
Fig. 3Effect of C. roseus matrix. Chromatograms of C. roseus extract solution before the SPE procedure (a), after the SPE procedure (b) and the standard solution after the SPE procedure (c). Conditions: Sorbent A (50 mm × 4.6 mm) and the HPLC system were combined using a ZORBAX Eclipse Plus C18 column (150 mm × 4.6 mm i.d., 5 μm), the flow rate was 1.0 mL/min, the wavelength was 220 nm, the samples were crude extract solution of C. roseus and the reference standard alkaloid solution (0.1 mg/mL), the injection volume was 5 μL, the eluent was 1.5 mL of MeOH-water (20:80, V/V), and the mobile phase was MeOH-ACN-water (0.2% triethylamine) (46:12:42, V/V/V). 1: vindoline; 2: catharanthine; 3: vincristine.
Fig. 4Effect of the mouse plasma matrix. Chromatograms of Uncaria alkaloid-spiked rat plasma before the SPE procedure (a), after the SPE procedure (b) and blank plasma after the SPE procedure (c). Conditions: Sorbent B (50 mm × 4.6 mm) and the HPLC system were combined using a COSMOSIL C18 column (250 mm × 4.6 mm i.d., 5 μm), the flow rate was 1.0 mL/min, the wavelength was 254 nm, the samples were blank plasma and alkaloid spiked plasma (0.02 mg/mL), the injection volume was 10 μL, the eluent was 5 mL of water, and the mobile phase was ACN-water (42:58, V/V). 1: isocorynoxeine; 2: isorhynchophylline; 3: corynoxeine; 4: rhynchophylline.
Fig. 5Determination of the alkaloids in (A) real C. roseus extract and (B) mouse plasma samples. Conditions for (A) were the same as those of Fig. 3b except for an injection volume of 20 μL; conditions for (B): a mouse (20 g in weight) received 50 μL of Uncaria extract (decocted with water) by intragastric administration, and blood was sampled after 1 h and was subsequently pre-treated following the given procedure. The other corresponding conditions were the same as those in Fig. 4b. 1: vindoline; 2: catharanthine; 3: vincristine; 1': isocorynoxeine; 2': isorhynchophylline; 3': corynoxeine; 4': rhynchophylline.